|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| C12Q 1/60 | |||
| A61P 9/10 | |||
| C07K 14/705 | |||
| G01N 33/92 | |||
| G01N 33/50 |
| (11) | Number of the document | 3292144 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16790128.9 |
| Date of filing the European patent application | 2016-05-06 | |
| (97) | Date of publication of the European application | 2018-03-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/031109 |
| Date | 2016-05-06 |
| (87) | Number | WO 2016/179456 |
| Date | 2016-11-10 |
| (30) | Number | Date | Country code |
| 201562158157 P | 2015-05-07 | US |
| (72) |
LIU, Yang, US
ZHENG, Pan, US
|
| (73) |
OncoImmune, Inc.,
9430 Key West Ave., Suite 113, Rockville, MD 20850,
US
|
| (54) | USE OF CD24 FOR LOWERING LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS |
| USE OF CD24 FOR LOWERING LOW-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS |